PapersFlow Research Brief
Bone and Joint Diseases
Research Guide
What is Bone and Joint Diseases?
Bone and Joint Diseases encompass a cluster of musculoskeletal conditions including osteonecrosis, osteoarthritis, and medication-related osteonecrosis of the jaw, focusing on their pathogenesis, natural history, and treatments such as stem cell therapy, core decompression, and pharmacological interventions.
This field includes 38,953 published works on bone and joint diseases. Research emphasizes osteonecrosis of the femoral head, glucocorticoid-induced cases, bone marrow roles, MRI imaging, core decompression, and stem cell therapy. Key studies address osteoarthritis as abnormal joint tissue remodeling and alendronate's fracture risk reduction in women with vertebral fractures.
Topic Hierarchy
Research Sub-Topics
Femoral Head Osteonecrosis
Studies elucidate the epidemiology, staging, and natural progression of avascular necrosis in the femoral head, emphasizing early detection and risk stratification. Researchers correlate clinical outcomes with imaging and biomarkers.
Core Decompression
Research evaluates the efficacy of core decompression techniques alone or with adjuncts like bone grafting for early-stage osteonecrosis. Randomized trials assess pain relief, collapse prevention, and long-term survival rates.
Stem Cell Therapy Osteonecrosis
Investigates mesenchymal stem cell implantation combined with decompression for regenerating bone marrow and preventing femoral head collapse. Clinical trials compare cell sources, delivery methods, and outcomes versus controls.
Glucocorticoid-Induced Osteonecrosis
Focuses on pathogenesis, including apoptosis, lipid metabolism, and intravascular coagulation triggered by corticosteroids. Studies identify genetic susceptibilities, dose-response relationships, and screening protocols.
MRI Imaging Osteonecrosis
Develops and validates MRI sequences for detecting marrow edema, necrosis extent, and collapse risk in osteonecrosis. Research integrates quantitative metrics with prognostic models and treatment response monitoring.
Why It Matters
Bone and joint diseases contribute to pain and disability, with osteoarthritis recognized as the most common arthritis form affecting older adults through abnormal remodeling of joint tissues rather than mere wear and tear, as detailed in "Osteoarthritis: A disease of the joint as an organ" by Loeser et al. (2012). Alendronate reduced the risk of new vertebral fractures by 47% and hip fractures by 51% over three years in women with existing vertebral fractures, according to the randomised trial by Black et al. (1996). "American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update" by Ruggiero et al. (2014) provides management guidelines for osteonecrosis linked to medications like bisphosphonates, impacting oral surgery and oncology patients.
Reading Guide
Where to Start
"Osteoarthritis: A disease of the joint as an organ" by Loeser et al. (2012) provides an accessible entry into joint pathophysiology, explaining osteoarthritis beyond wear-and-tear as organ-level disease.
Key Papers Explained
Kellgren and Lawrence (1957) "Radiological Assessment of Osteo-Arthrosis" established diagnostic imaging standards foundational for later works. Black et al. (1996) "Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures" built evidence for bisphosphonate therapy in fracture prevention. Loeser et al. (2012) "Osteoarthritis: A disease of the joint as an organ" reframed osteoarthritis mechanisms, while Ruggiero et al. (2014) "American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update" applied similar risk insights to jaw osteonecrosis.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research extends MRI diffusion techniques from papers like Le Bihan et al. (2001) to model bone marrow edema in early osteonecrosis. Frontiers involve refining stem cell protocols for femoral head repair and staging medication-related osteonecrosis.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Radiological Assessment of Osteo-Arthrosis | 1957 | Annals of the Rheumati... | 12.1K | ✓ |
| 2 | Randomised trial of effect of alendronate on risk of fracture ... | 1996 | The Lancet | 3.8K | ✕ |
| 3 | Probabilistic diffusion tractography with multiple fibre orien... | 2006 | NeuroImage | 3.5K | ✓ |
| 4 | Diffusion tensor imaging: Concepts and applications | 2001 | Journal of Magnetic Re... | 3.5K | ✕ |
| 5 | NODDI: Practical in vivo neurite orientation dispersion and de... | 2012 | NeuroImage | 3.3K | ✕ |
| 6 | Characterization and propagation of uncertainty in diffusion‐w... | 2003 | Magnetic Resonance in ... | 3.1K | ✕ |
| 7 | Osteoarthritis: A disease of the joint as an organ | 2012 | Arthritis & Rheumatism | 2.9K | ✕ |
| 8 | American Association of Oral and Maxillofacial Surgeons Positi... | 2014 | Journal of Oral and Ma... | 2.8K | ✕ |
| 9 | Diffusion Tensor Imaging of the Brain | 2007 | Neurotherapeutics | 2.6K | ✓ |
| 10 | Dysmyelination Revealed through MRI as Increased Radial (but U... | 2002 | NeuroImage | 2.6K | ✕ |
Frequently Asked Questions
What is osteonecrosis in bone and joint diseases?
Osteonecrosis, also known as avascular necrosis, involves bone tissue death due to disrupted blood supply, particularly in the femoral head. Research covers its glucocorticoid-induced forms, bone marrow involvement, and diagnosis via MRI imaging. Treatments include core decompression and stem cell therapy.
How does alendronate treat bone diseases?
Alendronate reduces fracture risk in women with existing vertebral fractures. Black et al. (1996) reported a 47% reduction in new vertebral fractures and 51% in hip fractures over three years. It targets bone density loss in osteoporosis-related joint conditions.
What defines osteoarthritis pathophysiologically?
Osteoarthritis involves abnormal remodeling of joint tissues, not just degeneration. Loeser et al. (2012) describe it as a disease of the joint as an organ, causing pain and disability in older adults. It affects cartilage, synovium, and subchondral bone.
What is medication-related osteonecrosis of the jaw?
Medication-related osteonecrosis of the jaw arises from drugs like bisphosphonates used in osteoporosis or cancer treatment. Ruggiero et al. (2014) updated position paper outlines its diagnosis, risk factors, and staging. Management includes conservative therapy and surgery.
How is osteo-arthrosis assessed radiologically?
Radiological assessment of osteo-arthrosis uses standardized grading for joint space narrowing and osteophytes. Kellgren and Lawrence (1957) established criteria still referenced in orthopedic research. It aids in diagnosing bone and joint disease progression.
What role does MRI play in bone and joint diseases?
MRI provides insights into osteonecrosis pathogenesis and early detection via bone marrow changes. Diffusion MRI techniques characterize tissue microstructure in joint-related conditions. It supports treatment planning for femoral head osteonecrosis.
Open Research Questions
- ? How do glucocorticoid exposures initiate femoral head osteonecrosis at the cellular level?
- ? What biomarkers in bone marrow predict progression from early to advanced osteonecrosis?
- ? Which patient subgroups benefit most from combined core decompression and stem cell therapy?
- ? How does joint organ-wide remodeling in osteoarthritis respond to targeted anti-inflammatory interventions?
- ? What preventive strategies reduce medication-related osteonecrosis of the jaw in bisphosphonate users?
Recent Trends
The field maintains 38,953 works with sustained focus on osteonecrosis pathogenesis and MRI diagnostics, as no growth rate data is available.
Recent citations reaffirm classics like Kellgren and Lawrence with 12,097 citations for radiological standards and Black et al. (1996) with 3,833 for alendronate trials.
1957Research Bone and Joint Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Bone and Joint Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers